It has been reported that IFI27 protein plays diverse roles in anti-tumor immunity, including suppressing the transcription of PD-L1 and promoting epithelial–mesenchymal transition (Li et al, 2015; Deng et al, 2020). The gene discussed is CD274; the disease is neoplasm.